Computer navigation-guided percutaneous radiofrequency ablation of the osteoid osteomas:13-case report

Feng YU,Qing ZHANG,Hai-tao ZHAO,Li-hui XU,Xiao-hui NIU

DOI: https://doi.org/10.3969/j.issn.2095-252X.2014.02.016

2014-01-01

Abstract:Objective To investigate the surgical method and clinical results of computer navigation-guided percutaneous radiofrequency ablation ( RFA ) in the treatment of osteoid osteomas. Methods From June 2011 to November 2012, 13 patients with osteoid osteomas were treated with computer navigation-guided percutaneous RFA, whose clinical data were retrospectively analyzed. There were 12 men and 1 woman with a mean age of 16.5 years old ( range;8-36 years ). Preoperatively all the diagnoses were conifrmed by the local X-ray, CT and MRI examinations. The femoral diaphysis was the most common site involved ( n=4 ), followed by the femoral trochanter ( n=2 ), the femoral neck ( n=2 ), the femoral condyle ( n=2 ), the tibial diaphysis ( n=2 ) and the calcaneus ( n=1 ). The intraoperative scanning with the C-arm Iso-C three-dimensional ( 3-D ) system ( Siemens ) was performed and the spine navigation system ( Stryker ) was used in all the cases. The core needle biopsy ( 9G ) which was guided by the navigation system was performed in the nidus, and the the outer sleeve was reserved as an access for the radiofrequency needle. The RFA was performed at 90℃for 6 minutes. All the patients were followed up postoperatively. The Visual Analogue Scale (VAS) was used before and after the surgery, and the X-ray and CT examinations were performed after the surgery to evaluate the results. Results All the 13 patients were followed up for 11.2 months on average ( range;4-20 months ), and they all underwent computer navigation-guided RFA successfully. Histopathological examination revealed 11 cases of osteoid osteomas and 2 cases of no diagnosis, and the pathological diagnosis rate was 85%. The postoperative pain got relieved instantly. The VAS scores were signiifcantly reduced, which were 4.7 points, 1.3 points and 0.1 points on average preoperatively and at 3 days and 3 months after the operation respectively, and the differences were statistically signiifcant ( P<0.05 ). Neither tumor recurrence nor pain relapse was found in all the patients during the follow-up. Conclusions Percutaneous RFA is a feasible, safe and effective method in the treatment of osteoid osteomas, with the advantages of more accurate positioning when inserting the needle in the nidus and minimally invasiveness under the guidance of computer navigation.